Ulipristal acetate (Esmya): restrictions on use
- PMID: 30297449
- DOI: 10.1136/dtb.2018.11.000033
Ulipristal acetate (Esmya): restrictions on use
Abstract
Safety alert: Esmya (ulipristal acetate) for symptoms of uterine fibroids: restrictions to use and requirement to check liver function before, during and after treatment.1,2.
© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources